MORPHOLOGIC ABNORMALITIES OF BONE MARROW CELLS INDUCED BY CHEMOTHERAPEUTIC AGENTS DURING TREATMENT OF LEUKEMIA.
D000970:Antineoplastic Agents; D001854:Bone Marrow Cells; D004358:Drug Therapy; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D015122:Mercaptopurine; D008727:Methotrexate; D010336:Pathology; D011241:Prednisone / Q000627:therapeutic use*; D014116:Toxicology; D014750:Vincristine
D000970:Antineoplastic Agents; D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate
ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; DRUG THERAPY; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; MERCAPTOPURINE; METHOTREXATE; PATHOLOGY; PREDNISONE, THERAPEUTIC; TOXICOLOGIC REPORT; VINCRISTINE